PURIFICATION: A KEY PROCESS IN THE PHARMACEUTICAL INDUSTRY

Separative introduces a new source of value creation thanks to its molecule purification innovation, especially for the sample purification. Prolonged R&D times and high equipment costs are not inevitable!

 

The pharmaceutical industry is affected by three factors:

separative_icone_reglementation
regulations
(pharmacopoeia, GMP)
separative_icone_retd
The R&D investments required to
bring an active ingredient to market
separative_icone_couts
equipment costs,
especially because of the pressure

SEPARATIVE offers a breakthrough technology, protected by two patents, to optimise:

Efficiency

The precision obtainable in the analysis of synthesised samples is limited by the cost of current technologies. The exploratory scope of molecules is therefore restricted and therapeutic innovations are inhibited. Significantly pushing back the boundaries of knowledge by multiplying the analytical capability can release all the potential for therapeutic innovations.

Time

Because the protection provided by a patent has a time limit, the market introduction time for a new active ingredient is an important issue. Molecule separation, whether for the purpose of analysis or sample purification, is one of the most common R&D operations. Reducing the time taken by an operation or the number of operations to be carried out to achieve the expected separation is a huge potential source of value creation.

Volume

The volumes processed to analyse or purify pharmaceutical products are enormous. And every operation requires the use of solvents. Solvents are expensive, harmful, and one of the main time-consuming steps in the separation operation. Consuming less solvent for a given separation considerably reduces the cost of the operation and is good for the environment!

The equipment

Pressure: the main factor in equipment costs! The ability to perform the same operations at low pressure considerably reduces equipment costs. Because chromatography is the most efficient separation method, it is becoming the standard.

Other molecule industries

Our ultra high-performance low-pressure columns open up immense potential for innovation in all molecule industries.

 

They provide three value-creation levers according to the application:

separative_icone_reduction_cout
substantial reduction
in investment costs
separative_icone_productivite
increased
operating productivity
separative_icone_analyses
carrying out analyses
that were not possible until now

We work in close collaboration with experts from every sector to produce a breakthrough in molecule separation techniques.